However, shifting these cells to modified media (containing knockout serum replacement, KOSR) without dexamethasone provides a culture condition that leads to a higher level of endogenous DUX4 expression in FSHD cells [34]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.